These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3234735)

  • 21. [Possibilities and results of the use of a cell separator in hematology].
    Stacher VA; HOCKER P; Pittermann E
    Wien Med Wochenschr; 1975 Jan; 125(1-3):35-44. PubMed ID: 236623
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reactions observed in blood donors and patients during cytapheresis on the blood cell separator].
    Gorodetskiĭ VM
    Ter Arkh; 1978; 50(7):129-31. PubMed ID: 715711
    [No Abstract]   [Full Text] [Related]  

  • 23. Availability of plasma fractions for therapeutic use in Italy. (An introduction to the conference).
    Mannucci PM
    Ric Clin Lab; 1983; 13(1):1-4. PubMed ID: 6857093
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
    Nazarchuk LV; Fedorovskaia EA
    Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful treatment of thyroid storm by continuous plasmapheresis with a blood-cell separator (author's transl)].
    Horn K; Brehm G; Habermann J; Pickardt CR; Scriba PC
    Klin Wochenschr; 1976 Oct; 54(20):983-6. PubMed ID: 979079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of temperature on the donor and the thrombocyte function in thrombopheresis with a cell separator (Aminco)].
    Wysk J; Schüttler W; Stangel W
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):110-1. PubMed ID: 565748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A method of plasmapheresis in patients with hereditary hypercholesterolemia].
    Kulakov GP; Kukharchuk VV; Konovalov GA; Barsukov IuF; Semavin IE
    Ter Arkh; 1985; 57(7):107-8. PubMed ID: 4049259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of red cell mass in a plasmapheresis machine: effect of rinsing the disposable tubing with normal saline and reinfusion.
    Fischer T; Surikova I; Heesen E; Wilms G; Laitinen T; Taborski U
    Transfus Apher Sci; 2013 Aug; 49(1):80-3. PubMed ID: 23769170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G levels during collection of large volume plasma for fractionation.
    Burkhardt T; Rothe R; Moog R
    Transfus Apher Sci; 2017 Jun; 56(3):417-420. PubMed ID: 28454884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic plasmapheresis].
    Dvoretskiĭ LI; Vorob'ev PA; Ryzhko VV
    Ter Arkh; 1984; 56(6):137-44. PubMed ID: 6382670
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood donation (selection of donors, protection of donors and recipients, collection technics, possible complications, methods of blood donation].
    Wegener S
    Z Arztl Fortbild (Jena); 1982 Feb; 76(3):77-82. PubMed ID: 7043917
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of plasmapheresis in pediatrics].
    Zhukov EA; Marochkin VS; Poltorabot'ko VI; Kropin NN
    Vestn Khir Im I I Grek; 1989 Nov; 143(11):84-5. PubMed ID: 2633447
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch].
    Shimoyama M; Minato K; Kitahara T
    Rinsho Ketsueki; 1981 Oct; 22(10):1661-6. PubMed ID: 6174751
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasmapheresis as a method of obtaining donors' antistaphylococcal plasma].
    Konstantinov VN
    Sov Med; 1978 May; (5):99-103. PubMed ID: 675328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood coagulation and fibrinolysis in blood donors after plasmapheresis].
    Zukowska B; Kotschy M
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):120-2. PubMed ID: 1437797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plateletpheresis concentrates produced in 30 minutes along with plasma and packed red cells: preliminary results.
    Valbonesi M; Frisoni R; Capra C; Lercari G; Fella M; Pittaluga P
    J Clin Apher; 1988; 4(4):152-4. PubMed ID: 3220817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of plasmapheresis on the protein-synthetic function of the liver and several immunologic indices of reactivity of the donor organism].
    Konstantinov VN
    Probl Gematol Pereliv Krovi; 1970 Jul; 15(7):50-1. PubMed ID: 5484235
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
    Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
    Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.